1 hour ago
4
CHI Pharmaceuticals, a member of the Tropical General Investment (TGI) Group, and EVA Pharma, a leading global healthcare solutions provider acting across over 70 countries, have announced a strategic partnership with the aim to expand access to essential medicines for patients in Nigeria.
The partnership according to the organisations will leverage CHI Pharmaceuticals’ local expertise and EVA Pharma’s extensive portfolio ‒ covering more than 10 therapeutic areas ‒ to address pressing patients’ needs.
The partnership which covers metabolic health, diabetes, and virology especially hepatitis B was unveiled at the an event held at the CHI Pharmaceuticals’ headquarters in Lagos, Nigeria.
The event was attended by EVA Pharma’s Nigeria Country Manager, David Otokpa; and Marketing Lead of West Africa, Bishoy Faltas.
Following the shared mission of capacity building, the event included an onboarding session to familiarize CHI Pharma’s personnel with EVA Pharma’s wide products portfolio.
Shriram Iyer, Chief Operating Officer (COO) of CHI Pharmaceuticals, highlighted the strategic alignment between both companies in their vision to improve healthcare outcomes in Nigeria.
“We are excited to collaborate with EVA Pharma, a company renowned for its innovative approach and patient-centric solutions. This partnership demonstrates our ongoing commitment to providing Nigerians with high-quality and affordable healthcare products.
“With this alliance, we are expanding our reach and strengthening our healthcare services, enabling us to meet the healthcare needs of millions of Nigerians,” Iyer said.
Bishoy Faltas, Marketing Lead for West Africa at EVA Pharma, said that the collaboration is a significant milestone in the company’s on-going mission to support all communities across Africa by providing innovative and accessible healthcare solutions.
“We hope that Nigerian patients would benefit from available and affordable life-saving medicines, contributing to their overall health and well-being.”
Dr. Sylvia Vito, Sub-Sahara Africa Head at EVA Pharma, said, “We are deeply committed to improving access to essential healthcare across the Sub-Sahara region through partnerships and collaborations with local and regional companies and entities to ensure that life-saving treatments reach patients,” Vito said.
Similarly, both parties reaffirmed their commitment to advancing the partnership, which is expected to significantly enhance sustainable access to essential medicines in Nigeria, ultimately improving citizens’ health and well-being.
